Hsi Meng

Title: Hsi Meng - Innovator in Growth Hormone Research

Introduction

Hsi Meng, an accomplished inventor based in Terre Haute, Indiana, has made significant contributions to the field of biotechnology. With a keen focus on human growth hormone research, his work has paved the way for advancements in medical treatments and therapies.

Latest Patents

Meng holds a patent for Growth hormone-releasing factor analogs. This invention includes a specific sequence of Human Growth Hormone-Releasing Factor (hGRF) analogs represented as [Pro.sup.0, X.sup.15, Y.sup.27 ]-hGRF(1-A)-B. In this formulation, X can be selected from the amino acids Ala or Gly, while Y includes options such as Ile, Leu, Val, Nle, and Met. The variable A ranges from values 29-44, with B being NH.sub.2, OH, or COOH. These analogs are synthesized and administered to animals with the purpose of stimulating the release of Growth Hormone (GH), demonstrating significant potential in therapeutic applications.

Career Highlights

Hsi Meng is currently associated with Pitman-Moore, Inc., where he continues to innovate and advance research related to growth hormones. His dedication and expertise in biotechnology have made him a recognized figure in his field.

Collaborations

Throughout his career, Meng has collaborated with esteemed colleagues, including James E. Seely. Together, they have worked to expand the efficacy and applicability of growth hormone-related inventions, further contributing to the scientific community.

Conclusion

In conclusion, Hsi Meng stands out as a notable inventor whose work on growth hormone-releasing factor analogs has significant implications for medical science. His innovative spirit, coupled with collaborative efforts, continues to drive progress in the field of biotechnology and human health.